Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

NCT02955498 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

DRUG: Sevikar tab. 10/40mg
DRUG: Lodivikar tab. 5/40mg

Sponsor

Hanlim Pharm. Co., Ltd.